Abbott integrates CGM into Tandem's automated insulin pump

Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.

T1D Exchange on X: Abbott & #Tandem #DiabetesCare have announced the integration of the #FreeStyleLibre2 Plus #CGM into the #tslimX2 insulin pump. Cleared by the FDA in March 2023 for use with

Abbott partners with Omada, Tandem to extend the reach of its FreeStyle Libre CGM

FreeStyle Libre 2 Resources, freestyle libre 2

Manuel Hernández على LinkedIn: Environmental Protection Specialist

Adel Jahed posted on LinkedIn

Tandem Diabetes Care's T;SLIM x2 insulin pump is the first automated insulin delivery system to integrate with Abbott's new FreeStyle Libre 2 Plus sensor - Medical Update Online

Integration of Abbott and Tandem devices provide new option for diabetic patients

Shawn Noy on LinkedIn: #proudtobeabbott

Erica Scott - CSAM on LinkedIn: Vertex cuts ties to CRISPR Therapeutics' type 1 diabetes stem cell therapy

Tandem Diabetes Care Inc.